Generative AI — AI that can write essays, create artwork and music, and more — continues to attract outsize investor attention. We don’t know if this is going to hold up in humans and in different cell types, but it kind of shows you like there’s there’s something very potent and powerful about the ability to just reprogram the skin cell or neuron or the heart cell using epigenetics, even though we’re not tackling what could be other contributing factors to aging. But the company is forging ahead, planning to increase the size of its team from 24 employees to around 40 by the end of the year and spend the rest of the seed capital on R&D, infrastructure and product development